The parameters required to allow meaningful in vitro testing methods to be developed are illustrated on the basis of tablets, coated tablets, and capsules. The quantities of drug released are correlated with those measured in the blood. Correlated product specifications are derived from this for in vitro testing; these allow reproducible and controlled drug release in production, which is essential if adequate bioavailability is to be attained.
WeberEMutschlerE.Bioaequivalenz und Arzneimittelsicherheit: Sinn und Unsinn d. Arzneimittelsubstitution; Symposion d. Med. Pharmazeut. Studienges. e.V. (MPS) am 6. November 1986, Bonn-Mainz: MPS1987.
2.
The United States Pharmacopoeia. The National Formulary; 1990.
3.
The Pharmacopoeia of Japan. 11th edition (English version); 1986.
4.
European Pharmacopoeia. 2nd edition; 1980.
5.
Deutscher Arzneimittel-Codex.1986.
6.
Guidelines on Dissolution Testing of Solid Oral Products (Joint report of the Section for Control Laboratories and the Section of Industrial Pharmacists of the FIP).Pharm Ind. 1981;43(4);334–343.
